Annalisa Jenkins MBBS

Annalisa is a senior biotech executive, the Executive Chairman at Vium, and a Non-Executive Director at eight other biotech companies.

Annalisa was previously Head of R&D at Merck Serono and Global Medical Senior Vice-President at Bristol-Myers Squibb. She is the CEO of PlaqueTec, a company driving the future of personalised medicine in coronary artery disease, in addition to chairing or serving on the boards of a number of private and public companies in the life sciences industry, located in the US and the UK.